Moshirfar Majid, Chew Jesse, Werner Liliana, Meyer Jay J, Hunter Brian, Stevens Scott, Jensen Mike, Kleinmann Guy, Mamalis Nick
John A. Moran Eye Center, Old Mill Medical Center, Salt Lake City, Utah 84121, USA.
Graefes Arch Clin Exp Ophthalmol. 2008 Oct;246(10):1455-61. doi: 10.1007/s00417-008-0893-5. Epub 2008 Jul 19.
Gatifloxacin and moxifloxacin ophthalmic solutions are frequently prescribed for antimicrobial prophylaxis following cataract and corneal refractive surgeries, although the use of topical antibiotics is likely to interfere with wound healing in the immediate postoperative period. A potential factor that may influence rates of wound healing or corneal re-epithelialization is how the solutions are preserved. Gatifloxacin is preserved with 0.005% benzalkonium chloride, whereas moxifloxacin is unpreserved. The purpose of this study was to evaluate the effects of commercially prepared topical gatifloxacin and moxifloxacin on corneal re-epithelialization in rabbit eyes.
In this randomized, prospective, controlled study, 17 New Zealand white rabbits underwent bilateral corneal de-epithelialization procedures using 20% alcohol contained within a 6 mm trephine. Postoperatively, eyes were randomly assigned to receive either gatifloxacin 0.3%, moxifloxacin 0.5%, or balanced salt solution (BSS) four times daily. Each 6 hours during the first 2 days, and every 12 hours thereafter slit-lamp measurements and corneal photography were performed, enabling de-epithelialized surface areas to be calculated via EPCO 2000 computer analysis.
Gatifloxacin (n = 12) and moxifloxacin (n = 13) treated eyes had a statistically significant (p = 0.036) delay in epithelial healing relative to controls (BSS, n = 8). Healing rates of gatifloxacin and moxifloxacin treated eyes were not significantly different (p = 0.545).
We found no significant difference in re-epithelialization rates following topical application of gatifloxacin 0.3% and moxifloxacin 0.5%. Both antibiotic solutions delayed healing compared to BSS. Our analysis suggests that there was no apparent added epithelial toxicity due to the presence of BAK in the gatifloxacin preparation.
加替沙星和莫西沙星眼药水常用于白内障及角膜屈光手术后的抗菌预防,尽管局部使用抗生素可能会在术后即刻干扰伤口愈合。一个可能影响伤口愈合速度或角膜再上皮化的潜在因素是眼药水的保存方式。加替沙星用0.005%苯扎氯铵保存,而莫西沙星未添加防腐剂。本研究的目的是评估市售的局部用加替沙星和莫西沙星对兔眼角膜再上皮化的影响。
在这项随机、前瞻性、对照研究中,17只新西兰白兔使用6毫米环钻内的20%酒精进行双侧角膜上皮剥脱术。术后,将眼睛随机分为每日四次接受0.3%加替沙星、0.5%莫西沙星或平衡盐溶液(BSS)治疗。在头两天内每6小时,之后每12小时进行裂隙灯测量和角膜摄影,通过EPCO 2000计算机分析计算上皮剥脱面积。
与对照组(BSS,n = 8)相比,加替沙星治疗组(n = 12)和莫西沙星治疗组(n = 13)的眼睛上皮愈合有统计学意义的延迟(p = 0.036)。加替沙星和莫西沙星治疗组眼睛的愈合速度无显著差异(p = 0.545)。
我们发现局部应用0.3%加替沙星和0.5%莫西沙星后的再上皮化率无显著差异。与BSS相比,两种抗生素溶液均延迟了愈合。我们的分析表明,加替沙星制剂中存在苯扎氯铵并没有明显增加上皮毒性。